Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,031 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

NCT06772623

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital - Phoenix /ID# 272971 Phoenix, Arizona, United States
  • Providence - St. Jude Medical Center /ID# 271414 Fullerton, California, United States
  • FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 274450 Oxnard, California, United States
  • UCLA - Santa Monica /ID# 271690 Santa Monica, California, United States
View all 115 locations
View Trial Details
Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

NCT06218914

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +32 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Jacksonville, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

NCT07388524

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Helen F Graham Cancer Center Newark, Delaware, United States
  • Medical Oncology Hematology Consultants PA Newark, Delaware, United States
  • Kootenai Health - Coeur d'Alene Coeur d'Alene, Idaho, United States
  • Kootenai Clinic Cancer Services - Post Falls Post Falls, Idaho, United States
View all 20 locations
View Trial Details
Recruiting

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

NCT07554339

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • NHO Revive Research Institute LLC ( Site 0118) Lincoln, Nebraska, United States
  • New York Oncology Hematology P.C ( Site 9000) Albany, New York, United States
  • Clinica Adventista Belgrano ( Site 0304) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Instituto de Investigaciones Clínicas Mar del Plata ( Site 0303) Mar del Plata, Buenos Aires, Argentina
View all 50 locations
View Trial Details
Recruiting

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

NCT04165070

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0001) Gilbert, Arizona, United States
  • City of Hope ( Site 0014) Duarte, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0007) San Francisco, California, United States
  • Georgetown University ( Site 0036) Washington D.C., District of Columbia, United States
View all 46 locations
View Trial Details

Related conditions